Therapeutic Asset Ratings
705 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Busulphan
Chronic Granulomatous Disease
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
Busulphan
Common Variable Immunodeficiency
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
Busulphan
Griscelli Syndrome
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
Busulphan
Hyper-IgM Syndrome
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
Busulphan
Omenn Syndrome
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
Busulphan
Reticular Dysgenesis
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
Busulphan
Wiskott-Aldrich Syndrome
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
Busulphan
X-Linked Lymphoproliferative Syndrome
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
Cyclophosphamide
MHC Class II Deficiency
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
Cyclophosphamide
Chediak-Higashi Syndrome
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
Cyclophosphamide
Common Variable Immunodeficiency
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
Cyclophosphamide
Griscelli Syndrome
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
Cyclophosphamide
Hyper-IgM Syndrome
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
Cyclophosphamide
Omenn Syndrome
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
Cyclophosphamide
Reticular Dysgenesis
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
Evomela
MHC Class II Deficiency
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
Evomela
Griscelli Syndrome
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
Evomela
Omenn Syndrome
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
Evomela
Reticular Dysgenesis
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
FILGRASTIM
Bare Lymphocyte Syndrome
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
FILGRASTIM
CD40 Ligand Deficiency
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
FILGRASTIM
Chediak-Higashi Syndrome
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
FILGRASTIM
Chronic Granulomatous Disease
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
FILGRASTIM
Common Variable Immunodeficiency
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
FILGRASTIM
Griscelli Syndrome
Masonic Cancer Center, University of Minnesota
N/A
D
(30)
Showing 626 to 650 of 705 assets
Previous
Page 26 of 29
Next